| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 500nM RAD001 2hr; Passage: p22; |
Permissive
Robust
|
Homo sapiens |
GSE103023
...
|
MA0112.3
|
| ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 500 nM AZD201 2 hr; Passage: p22; |
Permissive
Robust
|
Homo sapiens |
GSE103023
...
|
MA0112.3
|
| ESR1 |
T47D (invasive ductal carcinoma) |
CellType: Mammary gland adenocarcarcinoma epithelial ceslls derived from metastatic site Modifications: parental cells |
Permissive
|
Homo sapiens |
GSE107176
...
|
MA0112.3
|
| ESR1 |
MDA-MB-134 (invasive lobular breast carcinoma) |
Treatment: DMSO Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line |
Permissive
Robust
|
Homo sapiens |
GSE109103
...
|
MA0112.3
|
| ESR1 |
MDA-MB-134 (invasive lobular breast carcinoma) |
Treatment: 100 nM estradiol (E2) for 1hr Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line |
Permissive
Robust
|
Homo sapiens |
GSE109103
...
|
MA0112.3
|
| ESR1 |
MDA-MB-134 (invasive lobular breast carcinoma) |
Treatment: a cocktail of 10 µM forskolin plus 100 µM 3-isobutyl-1-methylxanthine (FI) for 1hr Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line |
Permissive
Robust
|
Homo sapiens |
GSE109103
...
|
MA0112.3
|
| ESR1 |
Ishikawa (endometrial adenocarcinoma) |
Treatment: 100 nM Dexamethasone and 10 nM Estradiol for 1 hour |
Permissive
Robust
|
Homo sapiens |
GSE109891
...
|
MA0112.3
|
| ESR1 |
Ishikawa (endometrial adenocarcinoma) |
Treatment: 10 nM Estradiol for 1 hour |
Permissive
Robust
|
Homo sapiens |
GSE109891
...
|
MA0112.3
|
| ESR1 |
Ishikawa (endometrial adenocarcinoma) |
Treatment: DMSO (vehicle) for 1 hour |
Permissive
|
Homo sapiens |
GSE109891
...
|
MA0112.3
|
| ESR1 |
MCF7 (Invasive ductal breast carcinoma) |
DMSO |
Permissive
|
Homo sapiens |
GSE115607
...
|
MA0112.3
|
Showing 10 records in page 20
from 39 pages